JP Stock MarketDetailed Quotes
4593 Healios KK
- 147
- -1-0.68%
20min DelayMarket Closed Apr 26 15:00 JST
13.25BMarket Cap-2614P/E (Static)
151High145Low435.70KVolume147Open148Pre Close64.33MTurnover33252wk High1.06%Turnover Ratio90.13MShares11452wk Low-56.22EPS TTM6.05BFloat Cap2669Historical HighLossP/E (Static)41.18MShs Float114Historical Low-56.22EPS LYR4.05%Amplitude--Dividend TTM3.44P/B100Lot Size--Div YieldTTM
About Healios KK Company
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.
Company Profile
Symbol4593
Company NameHealios KK
Founded2011-02-24
MarketTSE Growth
Employees65
Fiscal Year Ends12-31
AddressWorld Trade Center Bldg. 15th Floor 2-4-1 Hamamatsucho
Zip Code100-0006
Phone03-4590-8009
Websitewww.healios.co.jp
Company Executives
- Name
- Position
- Salary
- Richard P. Kincaid
- Director
- --
- Michihisa Nishiyama
- Director
- --
- Tadanao Kagimoto
- Director
- --
- Glenn Gormley
- Independent Director
- --
- Yuko Yogo
- Independent Director
- --
- Seigo Kashii
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg